- Listed service
- 500 mg NAD+ mobile IV; subject to screening
- Booking
- ZIP code, requested time and coordinator confirmation
The advertised service and its price
Concierge MD's in-home NAD+ page lists a 500 mg NAD+ service at $799. That is a description of the advertised appointment, not a dose recommendation or a guarantee that every patient will receive it. Eligibility and the clinical plan remain part of the provider's screening process before treatment proceeds.
We classify this figure as a visit price. Comparing it directly with a month of delivered medication would mix different purchases: the mobile offer involves a clinical visit, whereas a telehealth vial may involve separate administration arrangements. The exact service and location should appear on the final estimate before the reader treats $799 as an all-in total.
How the mobile booking pathway works
The public page describes entering a ZIP code, choosing a preferred appointment time and receiving confirmation from a coordinator. Medical screening precedes the nurse's visit. This sequence matters because selecting a time is not the same as a confirmed appointment, and an advertised service area does not establish availability at every address.
Home, hotel and office visits are presented as options. Ask whether the intended location can accommodate the clinical service and whether any location or travel charge applies. Statements about quick arrival should be checked with the booking team; we have not measured arrival times or verified same-day availability for a particular ZIP code.
What belongs in the $799 comparison
Ask which assessment, supplies, clinician time and administrative charges are included in the displayed service. If additional fluids or other ingredients are discussed, request a separate explanation and price rather than assuming they form part of the NAD+ listing. A more expensive appointment may contain more service, but that does not demonstrate a better clinical outcome.
Also obtain the rescheduling and cancellation terms before a visit is dispatched. A mobile appointment may create different costs from an unfulfilled pharmacy order. The provider's broad house-call billing information should not be interpreted as a guarantee of insurance reimbursement for this particular NAD+ service; confirm any coverage independently with the relevant insurer.
Evidence should follow the exact purpose
NAD+ is involved in normal cellular processes, and the provider links its service to wellness goals. Those statements do not establish that an IV visit improves energy, cognition or longevity for every person seeking it. The published NAD+ IV pilot in our source register is not proof of the full range of commercial wellness claims.
An informed discussion should identify the intended benefit, relevant evidence and uncertainties, as well as the preparation supplied. If compounded ingredients are used, ask the clinical team about pharmacy sourcing and quality controls. FDA's sterile-compounding guidance is relevant to product quality; it does not endorse a particular clinic or prove that a marketed benefit will occur.
A useful decision before arranging a visit
The most practical next step is a location-specific written quote linked to the proposed appointment and screening process. It should identify the responsible clinical team, the service, the final total and any conditions that could change the plan. Keep that document separate from a general NAD+ information page.
This offer gives readers a concrete mobile-service benchmark of $799, with unresolved details that need confirmation. Its comparison value lies in understanding what a visit purchases. It should not be used to derive an injection schedule, to rank routes by the amount listed or to assume that a higher service charge buys a more effective treatment.
Sources & further reading
Official pages and evidence consulted for this article. Checked October 11, 2026. Provider pages establish advertised terms; they do not independently establish effectiveness.